A steroid-conjugated contrast agent for magnetic resonance imaging of cell signaling

Journal of the American Chemical Society

Volumn 127, Issue 38, 2005, Pages 13164-13166

  Lee, Jiyoun ^a   Zylka, Mark J ^b   Anderson, David J ^b   Burdette, Joanna E ^a   Woodruff, Teresa K ^a   Meade, Thomas J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; AZIDE; BETA GALACTOSIDASE; CONTRAST MEDIUM; COPPER IODIDE; GADOLINIUM CHELATE; ISOTHIOCYANIC ACID DERIVATIVE; MIFEPRISTONE; MIFEPRISTONE GADOLINIUM COMPLEX; OXIME; PROGESTERONE; PROGESTERONE RECEPTOR; TRANSCRIPTION FACTOR GAL4; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONJUGATION; CONTROLLED STUDY; COVALENT BOND; CYTOLOGY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MITSUNOBU REACTION; NUCLEAR MAGNETIC RESONANCE IMAGING; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION;

BINDING, COMPETITIVE; GADOLINIUM; LIGANDS; MAGNETIC RESONANCE IMAGING; MIFEPRISTONE; MOLECULAR CONFORMATION; ORGANOMETALLIC COMPOUNDS; PROTEIN BINDING; RECEPTORS, PROGESTERONE; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 25444516833     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja051294x     Document Type: Article

References (27)

1. (a) Braselmann, S.; Graninger, P.; Busslinger, M. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 1657-1661.
2. (b) Jenster, G.; Spencer, T.; Burcin, M.; Tsai, S. Y.; Tsai, M.-J.; O'Malley, B. W. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 7879-7884.
3. (c) Osterwalder, T.; Yoon, K. S.; White, B. H.; Keshishian, H. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 12596-12601.
4. Zacharias, D. A.; Baird, G. S.; Tsien, R. Curr. Opin. Neurobiol. 2000, 10, 416-421.
5. (a) Jacobs, R. E.; Cherry, S. R. Curr. Opin. Neurobiol. 2001, 11, 621-629.
6. (b) Meade, T. J.; Taylor, A. K.; Bull, S. R. Curr. Opin. Neurobiol. 2003, 13, 597-602.
7. (c) Toth, E.; Helm, L.; Merbach, A. E. In Comprehensive Coordination Chemistry II, 2nd ed.; McCleverty, J. A., Meyer, T. J., Eds.; Elsevier: St. Louis, 2004; Vol. 9, pp 841-881.
8. Allen, M. J.; Meade, T. J. In Metal Ions in Biological Systems; Sigel, A., Sigel, H., Eds.; Marcel and Decker, Fontis Media: New York, 2004; Vol. 42, pp 1-38.
9. (a) Parker, D.; Williams, J. A. G. J. Chem. Soc., Dalton Trans. 1996, 3613-3628.
10. (b) Peters, J. A.; Huskens, J.; Raber, D. J. Prog. Nucl. Magn. Reson. Spectrosc. 1996, 28, 283-350.
11. (c) Aime, S.; Fasano, M.; Terreno, E. Chem. Soc. Rev. 1998, 27, 19-29.
12. (d) Aime, S.; Botta, M.; Fasano, M.; Terreno, E. Acc. Chem. Res. 1999, 32, 941-949.
13. Caravan, P.; Ellison, J. J.; McMurry, T. J.; Lauffer, R. B. Chem. Rev. 1999, 99, 2293-2352.
14. Lauffer, R. B. Chem. Rev. 1987, 87, 901-927.
15. (a) Louie, A. Y.; Huber, M. M.; Ahrens, E. T.; Rothbacher, U.; Moats, R.; Jacobs, R. E.; Fraser, S. E.; Meade, T. J. Nat. Biotechnol. 2000, 18, 321-325.
16. (b) Li, W. H.; Parigi, G.; Fragai, M.; Luchinat, C.; Meade, T. J. Inorg. Chem. 2002, 41, 4018-4024.
17. (c) Allen, M. J.; MacRenaris, K. W.; Venkatasubramanian, P. N.; Meade, T. J. Chem. Biol. 2004, 11, 301-307.
18. (a) Williams, S. P.; Sigler, P. B. Nature, 1998, 393, 392-396.
19. (b) Bursi, R.; Groen, M. B. Eur. J. Med. Chem. 2000, 35, 787-796.
20. (c) So, S.-S.; Van Helden, S. P.; Van Geerestein, V. J.; Karplus, M. J. Chem. Inf. Comput. Sci. 2000, 40, 762-772.
21. (d) Madauss, K. P.; Deng, S.-J.; Austin, R. J. H.; Lambert, M. H.; McLay, I.; Pritchard, J.; Short, S. A.; Stewart, E. L.; Uings, I. J.; Williams, S. P. J. Med. Chem. 2004, 47, 3381-3387.
22. Duggan, M. E.; Imagire, J. S. Synthesis 1989, 131-132.
23. Compound 3 was synthesized as previously reported for a bridged steroid synthesis: Mikola, H.; Hanninen, E. Bioconjugate Chem. 1992, 3, 182-186.
24. Two different isomers (syn/anti) of 3-oxime compound were synthesized when RU-486 was refluxed with hydroxylamine hydrochloride in pyridine. The isomers were separated by column chromatography on silica using the eluent of hexane:ethyl acetate = 1:1.
25. Eliminating isomerism (syn/anti at C3) may enhance the binding affinity. We attempted to separate the isomeric mixture to determine (if any) the effect that a purified isomer may have; however, we were unsuccessful.
26. (a) Stern, C. D.; Fraser, S. E. Nat. Cell Biol. 2001, 3, E216-E218.
27. (b) Duffy, J. B. Genesis 2002, 34, 1-15.